A Spotlight on Neurological Biomarkers
Neurological diseases are among the most complex, urgent challenges in human health. Advancing discovery in this space requires not only precision tools—but also the courage to ask difficult questions.
Uncover neurological complexity with pathway-level confidence
When used together in one study, Olink™ Target 48 Neurodegeneration and Olink™ Reveal can analyze 1,000+ protein biomarkers spanning established neurodegenerative markers and broader disease biology.
Identifying Alzheimer’s Disease Biomarkers: Insights for Diagnostics and Disease Monitoring
Explore advancements in blood-based biomarkers for Alzheimer’s disease in this webinar featuring Dr. Jason Jiang from the Hong Kong University of Science and Technology.
How PEA works
Unraveling the complexity of neurodegenerative diseases demands tools that can evaluate multiple biological pathways in parallel. PEA technology meets this need by merging an antibody-based immunoassay with the powerful properties of polymerase chain reaction (PCR). This provides a scalable multiplex protein biomarker platform with exceptional specificity and sensitivity while using minimal sample volumes.
Documents
Below are a few documents highlighting how PEA technology is being applied to tackle the complexity of neurological disease research.
Selected Publications
Neurological diseases
Aging
A flexible platform that accelerates your research
Olink’s scalable technology provides optimized solutions for every stage of the biomarker workflow, from high-throughput discovery through validation and clinical utility.
Get help choosing. Talk to a Specialist
Olink Explore HT
Measure 5,400+ proteins with proven specificity to gain an understanding of disease at the protein level.
Proteins
5,400+ With proven specificity
Sample
2 µL Plasma, serum & more
Olink Reveal
Accessible NGS-based proteomics for every lab. Unplugged from complexity, powered by insights
Proteins
>1,000 Powerful. Simple. Accessible
Sample
4 µL Plasma, serum & more
Olink Target 96
Target specific disease areas or key biological processes with multiplex immunoassay panels.
Proteins
92 11 targeted panels
Sample
1 µL Plasma, serum & more
Olink Target 48
Extensively validated and carefully selected biomarkers for a comprehensive view of immune and neurodegeneration processes.
Proteins
up to 45 3 panels
Sample
1 µL Plasma, serum & more